Kafui Dzirasa’s work on neuro-engineering technologies is nothing short of revolutionary, which hold great promise for treating psychiatric illnesses.

A more than 30-year commitment to understanding human metabolic regulation has helped Christopher Newgard discover new insights and potential new therapies for metabolic diseases such as diabetes, obesity, and cardiovascular disease.

Howard Rockman’s discoveries have led to new treatments for heart disease. He is a national expert and sought-after speaker on issues of cardiac atrophy and heart failure.

Anna Mae Diehl, the director of the Duke Liver Center, is heralded around the world for her work on liver regeneration and non-alcoholic fatty liver disease.

As founding director of the Duke Global Health Institute, Michael Merson is internationally respected as a seminal leader in global health and education.

Following in the footsteps of legendary Duke surgeon David Sabistan, current Chairman of Surgery Allan Kirk is one of the most respected transplant surgeons in the world.

Diane Havlir is a pioneer in HIV/AIDS research treatment, whose work has helped to transform HIV from a death sentence to a manageable chronic disease.

Researchers at the Duke Cancer Institute are teaming up with several other institutions to develop a fluorescent dye that is injected into cancerous tumors and lights up when viewed under a special camera. This allows surgeons to see if residual cancer remains after the tumor has been removed.

Why do perfectly good cancer treatments suddenly stop working? Researcher and lymphoma survivor Kris Wood is finding answers.

Radiation oncologist Karen Winkfield has been honored throughout the country for her research and advocacy to improve access and health outcomes for minorities.